The ELISA results showed that AS‐IV reduced the levels of IL‐18 and IL‐1β in the serum of rats with pulmonary hypertension (Figure 1H,I), and the inhibitory effect was similar to that of MCC950 and MDL‐28170. Here, IL18 is linked to pulmonary arterial hypertension.